Clinical and subclinical characteristics of breast cancer with I - II stages
Main Article Content
Abstract
Objectives: To describe some clinical and subclinical characteristics of patients with stage I-II breast cancer.
Subjects and methods: A prospective, cross-sectional descriptive study without a control group was conducted on 103 patients with stage I–II breast cancer who were diagnosed and treated at Military Hospital 175 from February 2018 to June 2022.
Results: The youngest patient age was 21 years old, the oldest age was 76 years old, the median age was 44 years old. The most common age group was from 40 - 59 years old, accounting for 65%. The position of the upper and outer quadrant was the most common, accounting for 56.3%. There were 63 patients with left breast cancer, accounting for 61.2%. The most common Invasive ductal breast cancer accounted for 74.8%. The highest proportion of patients was in the Luminal A group with 39.8%, followed by the Luminal B/HER2 group negative with 32%, the basal group with 16.5%, the HER2 (+) group with 8, 7% and the lowest group was Luminal B/HER2 (+) with 2.9%. The majority of patients in the study were in stage I at 51.4%, followed by stage IIA with 37.9%.
Conclusion: The most common age for breast cancer was 40-59 years old, usually in the upper-outer quarter position. Invasive ductal breast cancer was the most common. The highest percentage of patients was in the Luminal A group.
Article Details
Keywords
breast cancer stage I-II, Clinical, subclinical characteristics
References
2. Phạm Hồng Khoa. Ứng dụng phương pháp sinh thiết hạch cửa trong điều trị ung thư biểu mô tuyến vú giai đoạn sớm. Luận án Tiến sỹ Y học. Trường Đại học Y Hà Nội; 2016.
3. Nguyễn Đỗ Thùy Giang và cộng sự. Khảo sát tỷ lệ di căn hạch nách trong ung thư vú giai đoạn I-II. Tạp chí y học TP Hồ Chí Minh. Published online 2009.
4. D. Reitz S. Corradini, M. Pazos et al. Mastectomy or BreastConserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases. Cancers (Basel). 2019;11(2).
5. Lê Hồng Quang. Ứng Dụng Kỹ Thuật Hiện Hình và Sinh Thiết Hạch Cửa Trong Đánh Giá Tình Trạng Di Căn Hạch Nách Của Bệnh Nhân Ung Thư Vú. Luận án Tiến sỹ y học. Trường Đại học Y Hà Nội.; 2012.
6. G. Viale U. Veronesi, G. Paganelli et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595-600.
7. Pedram argani. Types of Breast Cancers: Histologic Examples of in Situ & Invasive Carcinomas of the Breast. John Hopkins medicine; 2012.
8. Hoàng Thanh Quang. Đánh Giá Kết Quả Điều Trị Bảo Tồn Ung Thư vú Nữ Giai Đoạn I-II Từ Năm 2003-2006 Tại Bệnh Viện K. Luận văn Thạc sỹ Y học. Trường Đại học Y Hà Nội; 2011.
9. Elston E.W and Ellis I.O. Method for grading breast cancer. J Clin Pathol. 1993;46(2):189-190.
10. W. Chen S. Basu, J. Tchou et al. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2- negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Cancer. 2008;112(5):995-1000.